Wall Street Experts
ver. ZuMIgo(08/25)
AbCellera Biologics Inc.
Rachunek Zysków i Strat
Przychody TTM (mln): 33
EBIT TTM (mln): -308
| index |
0 |
1 |
2 |
3 |
4 |
5 |
6 |
| Rok finansowy |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
| Przychód (mln) |
9 |
12 |
233 |
375 |
485 |
38 |
29 |
| Przychód Δ r/r |
0.0% |
31.5% |
1908.0% |
60.9% |
29.4% |
-92.2% |
-24.2% |
| Marża brutto |
100.0% |
12.9% |
88.4% |
87.9% |
86.3% |
18.8% |
100.0% |
| EBIT (mln) |
-1 |
-4 |
156 |
204 |
217 |
-237 |
-315 |
| EBIT Δ r/r |
0.0% |
446.7% |
-3889.9% |
31.0% |
5.9% |
-209.6% |
32.7% |
| EBIT (%) |
-8.5% |
-35.5% |
66.9% |
54.5% |
44.6% |
-623.8% |
-1091.7% |
| Koszty finansowe (mln) |
0 |
0 |
7 |
5 |
4 |
0 |
0 |
| EBITDA (mln) |
2 |
-0 |
170 |
242 |
276 |
-192 |
-204 |
| EBITDA(%) |
20.4% |
-2.9% |
72.9% |
64.6% |
56.9% |
-505.3% |
-708.0% |
| Podatek (mln) |
1 |
0 |
39 |
66 |
81 |
-28 |
-38 |
| Zysk Netto (mln) |
0 |
-2 |
119 |
153 |
159 |
-146 |
-163 |
| Zysk netto Δ r/r |
0.0% |
-883.1% |
-5014.2% |
29.1% |
3.3% |
-192.4% |
11.2% |
| Zysk netto (%) |
3.5% |
-20.8% |
51.0% |
40.9% |
32.7% |
-385.0% |
-564.8% |
| EPS |
0.0013 |
-0.0157 |
0.44 |
0.56 |
0.56 |
-0.51 |
-0.55 |
| EPS (rozwodnione) |
0.0013 |
-0.0157 |
0.44 |
0.48 |
0.5 |
-0.51 |
-0.55 |
| Ilośc akcji (mln) |
238 |
154 |
269 |
276 |
285 |
289 |
294 |
| Ważona ilośc akcji (mln) |
238 |
154 |
269 |
318 |
315 |
289 |
294 |
| Waluta |
USD |
USD |
USD |
USD |
USD |
USD |
USD |